Cardinal Health Inc.: 10-K Risk Factor Changes

2025 vs 2024  ·  SEC EDGAR  ·  2026-07-05
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

33
New Risks
22
Removed
120
Modified
29
Unchanged
🟢 New in Current Filing Severity9/10Det 9

Our results of operations and financial condition may be adversely affected by risks associated with entering new lines of business, and our ability to execute our strategy.

As a result of our recently announced acquisitions, we are entering into new lines of business, including providing physician practice support and management services, that complement our pre-existing businesses. Such new lines of business involve numerous risks and…

Read full text

As a result of our recently announced acquisitions, we are entering into new lines of business, including providing physician practice support and management services, that complement our pre-existing businesses. Such new lines of business involve numerous risks and uncertainties that may be different from or more significant than the risks and uncertainties facing our legacy businesses, including risks arising under or related to fraud, waste, and abuse laws, direct or indirect ownership of provider practices, litigation involving physicians, and risks from regulatory or legislative changes that may limit direct or indirect ownership of provider practices or our ability to provide physician practice support and management services. Additionally, these businesses are subject to cybersecurity risks that are, while similar in many respects, incremental to the cybersecurity risks experienced by our legacy businesses. If we are not able to adapt our systems and processes to mitigate these risks, we could experience additional financial losses, including as a result of class action lawsuits. Additionally, our ability to successfully execute on providing physician practice support and management services, including through direct or indirect ownership of provider practices as permitted by applicable law, depends upon a number of factors, including: the ability to develop or acquire and integrate appropriate practice management and support expertise; the ability to support recruitment, integration, and retention of sufficient numbers of local providers and staff; the ability to successfully support negotiations with vendors, suppliers, and payors; the reimbursement environment; and competition from other healthcare organizations with greater depth of experience or market knowledge.

🟢 New in Current Filing Notes to Financial Statements 🔒
🟢 New in Current Filing Notes to Financial Statements 🔒
🟢 New in Current Filing Notes to Financial Statements 🔒
🟢 New in Current Filing Notes to Financial Statements 🔒
🟢 New in Current Filing Solaris Health 🔒
🟢 New in Current Filing Exhibits, Financial Statement Schedules 🔒
🔴 No Match in Current Filing Risk Factors 🔒
🟡 Modified Our ability to complete, integrate, and manage acquisitions could impact our strategic objectives and financial condition. 🔒
🟡 Modified Risk Factors 🔒
🟡 Modified Our business and operations depend on the proper functioning of information systems, critical facilities, and distribution networks and could be negatively impacted by events outside of our control. 🔒
🟡 Modified Changes or uncertainty in U.S. or international trade policies and exposure to economic, political and currency, and other risks could disrupt our global operations or negatively impact our financial results. 🔒
🟢 New in Current Filing The outcome or resolution of certain legal proceedings could adversely impact our cash flows or results of operations. 🔒
🟢 New in Current Filing Consolidated Statements of Earnings 🔒
🟢 New in Current Filing Vendor Reserves 🔒
🟢 New in Current Filing Income Taxes 🔒
🟢 New in Current Filing Variable Interest Entities 🔒
🟢 New in Current Filing Consolidated Variable Interest Entities 🔒
🟢 New in Current Filing GIA Share-Based Compensation 🔒
🟢 New in Current Filing Advanced Diabetes Supply Group ("ADS") 🔒
🟢 New in Current Filing GI Alliance ("GIA") 🔒
🟢 New in Current Filing Integrated Oncology Network ("ION") 🔒
🟢 New in Current Filing Specialty Networks 🔒
🟢 New in Current Filing Fair Value of Assets Acquired and Liabilities Assumed 🔒
🟢 New in Current Filing Opioid Lawsuits and Investigations 🔒
🟢 New in Current Filing Segment Profit 🔒
🟢 New in Current Filing GIA Share-Based Compensation 🔒
🟢 New in Current Filing Vested at June 30, 2025 🔒
🟢 New in Current Filing Schedule II - Valuation and Qualifying Accounts 🔒
🟢 New in Current Filing Information About Our Executive Officers 🔒
🟢 New in Current Filing Directors and Corporate Governance 🔒
🔴 No Match in Current Filing Opioid Lawsuits and Investigations 🔒
🟡 Modified Product quality issues could adversely affect operations, profitability, cash flows, and our financial condition. 🔒
🟡 Modified Our business and results of operations could be adversely affected if we experience a material cyber-attack or other systems breach. 🔒
🟡 Modified Risk Factors 🔒
🟡 Modified Risk Factors 🔒
🟡 Modified Our business is affected by events outside of our control including public health crises, extreme weather-related events and natural disasters, geopolitical, and other catastrophic events. 🔒
🟡 Modified Changes to the U.S. healthcare environment may not be favorable to us. 🔒
🟡 Modified Risk Factors 🔒
🟢 New in Current Filing Earnings per common share attributable to Cardinal Health, Inc. 🔒
🟢 New in Current Filing Total comprehensive income attributable to Cardinal Health, Inc. 🔒
🟢 New in Current Filing Tax Effects of Goodwill Impairment Charges 🔒
🟢 New in Current Filing Fair Value of Financial Instruments 🔒
🟢 New in Current Filing Diluted earnings per common share attributable to Cardinal Health, Inc.: 🔒
🟢 New in Current Filing Restricted Share Units 🔒
🟢 New in Current Filing Sudhakar Ramakrishna 🔒
🔴 No Match in Current Filing Updated Segment Reporting Structure 🔒
🔴 No Match in Current Filing Fair Value of Financial Instruments 🔒
🟡 Modified Risk Management and Strategy 🔒
🟡 Modified Our business is subject to rigorous regulatory and licensing requirements. 🔒
🟡 Modified Risk Factors 🔒
🟡 Modified products and raw materials available to us and are subject to fluctuations in costs, availability, and regulatory risk associated with these products and raw materials. 🔒
🟡 Modified Risk Factors 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified 1. Basis of Presentation and Summary of Significant Accounting Policies 🔒
🟡 Modified Risk Factors 🔒
🟡 Modified Risk Factors 🔒
🟡 Modified Property and Equipment 🔒
🟡 Modified 4. Restructuring and Employee Severance 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🔴 No Match in Current Filing Our business could be affected by activist shareholders. 🔒
🔴 No Match in Current Filing Uncertain Tax Positions 🔒
🔴 No Match in Current Filing Consolidated Statements of Earnings/(Loss) 🔒
🔴 No Match in Current Filing Revision of Prior Period Consolidated Financial Statements 🔒
🔴 No Match in Current Filing Notes to Financial Statements 🔒
🔴 No Match in Current Filing Notes to Financial Statements 🔒
🔴 No Match in Current Filing Investments 🔒
🔴 No Match in Current Filing Notes to Financial Statements 🔒
🔴 No Match in Current Filing Notes to Financial Statements 🔒
🔴 No Match in Current Filing Notes to Financial Statements 🔒
🔴 No Match in Current Filing Assets Measured on a Nonrecurring Basis 🔒
🔴 No Match in Current Filing Segment Profit 🔒
🔴 No Match in Current Filing 16. Revision of Previously Issued Financial Statements (Unaudited) 🔒
🟡 Modified Other Financing Arrangements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified 10. Fair Value Measurements 🔒
🟡 Modified Receivables and Allowance for Doubtful Accounts 🔒
🟡 Modified Failure to effectively or efficiently complete or manage critical business processes could have unforeseen consequences. 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified 11. Financial Instruments 🔒
🟡 Modified Our results of operations or strategic objectives could be adversely impacted if we fail to manage and complete divestitures. 🔒
🟡 Modified Inventories 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Cash Flow Hedges 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Opioid-related legal proceedings and the NOSA we have entered into could have additional or unexpected negative effects on our results of operations or business. 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified 14. Segment Information 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Cardinal Health, Inc. Plan 🔒
🟡 Modified 5. Goodwill and Other Intangible Assets 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Effective Tax Rate 🔒
🟡 Modified Earnings before income taxes 🔒
🟡 Modified Long-Term Debt 🔒
🟡 Modified Net earnings attributable to Cardinal Health, Inc. 🔒
🟡 Modified Commodity Price Risk Management 🔒
🟡 Modified New York Opioid Stewardship Act 🔒
🟡 Modified Total net assets acquired 🔒
🟡 Modified Major Customers 🔒
🟡 Modified Business Combinations 🔒
🟡 Modified Amortization and Other Acquisition-Related Costs 🔒
🔴 No Match in Current Filing Changes to the U.S. healthcare environment may not be favorable to us. 🔒
🔴 No Match in Current Filing As Reported 🔒
🔴 No Match in Current Filing Self-Insurance 🔒
🔴 No Match in Current Filing Total net assets acquired 🔒
🔴 No Match in Current Filing Deferred Income Taxes 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Fair Value Hedges 🔒
🟡 Modified Notes to Financial Statements 🔒
🟡 Modified Other Civil Litigation 🔒
🟡 Modified We could be subject to adverse changes in the tax laws or challenges to our tax positions. 🔒
🟡 Modified Legal Proceedings 🔒
🟡 Modified Economic (Non-Designated) Hedges 🔒
🟡 Modified Unrecognized Tax Benefits 🔒
🟡 Modified We could continue to suffer the adverse effects of competitive pressures, and changes in our relationships with significant customers could adversely affect us. 🔒
🟡 Modified Investments 🔒
🟡 Modified Consolidation in the U.S. healthcare industry may negatively impact our results of operations. 🔒
🟡 Modified Our Pharmaceutical and Specialty Solutions segment’s profit margin could be adversely affected by changes in industry or market dynamics that we are not able to accurately predict. 🔒
🟡 Modified Net deferred income tax liability 🔒
🟡 Modified Goodwill and Other Intangible Assets 🔒
🟡 Modified Performance Share Units 🔒
🟡 Modified Expected Volatility (3) 🔒
🟡 Modified Critical Audit Matter 🔒
🟡 Modified Other Intangible Assets 🔒
🟡 Modified Cordis IVC Filter Matters 🔒
🟡 Modified Recently Adopted Financial Accounting Standards. 🔒
🟡 Modified Balance at end of fiscal year 🔒
🟡 Modified Earnings before Income Taxes and Provision for Income Taxes 🔒
🟡 Modified Deferred Income Taxes 🔒
🟡 Modified PeriodTotal Numberof SharesPurchased (1)Average Price Paid per ShareTotal Number of SharesPurchasedas Part of Publicly Announced Programs (2)ApproximateDollar Value ofShares That MayYet be PurchasedUnder the Programs (2)(in millions)April 20257 $133.13 — $2,743 May 20256 150.62 — 2,743 June 20257 158.38 — 2,743 Total20 $147.17 — $2,743 🔒
🟡 Modified Net Investment Hedges 🔒
🟡 Modified Antitrust Litigation Proceeds 🔒
🟡 Modified 12. Shareholders' Deficit 🔒
🟡 Modified Interest Rate, Currency, and Commodity Risk 🔒
🟡 Modified Accumulated Other Comprehensive Loss 🔒
🟡 Modified Identifiable net assets/(liabilities): 🔒
🟡 Modified Valuation of Goodwill 🔒
🟡 Modified Loss Contingencies 🔒
🟡 Modified Noncontrolling Interests 🔒
🟡 Modified Our goodwill or other long-lived assets may be further impaired, which could require us to record additional significant charges to earnings in accordance with generally accepted accounting principles. 🔒
🟡 Modified Assets Held for Sale 🔒
🟡 Modified Employee Retirement Savings Plans 🔒
🟡 Modified 13. Earnings Per Share Attributable to Cardinal Health, Inc. 🔒
🟡 Modified Total share-based compensation expense 🔒
🟡 Modified 7. Long-Term Obligations and Other Short-Term Borrowings 🔒
🟡 Modified Consolidated Statements of Shareholders' Deficit 🔒
🟡 Modified Five Year Performance Graph 🔒
🟡 Modified Restructuring and Employee Severance 🔒
🟡 Modified Our sales and credit concentration is significant. 🔒
🟡 Modified Changes in Internal Control Over Financial Reporting 🔒
🟡 Modified Consolidated Statements of Comprehensive Income 🔒
🟡 Modified Financial Statements and Supplementary Data 🔒
🟡 Modified Recently Issued Financial Accounting Standards and Disclosure Rules Not Yet Adopted 🔒
🟡 Modified Consolidated Statements of Cash Flows 🔒
🟡 Modified 3. Divestitures 🔒
🟡 Modified Consolidated Balance Sheets 🔒
🟡 Modified Legal Proceedings 🔒
🟡 Modified Concentrations of Credit Risk 🔒
🟡 Modified Opinion on the Financial Statements 🔒
🟡 Modified Sales Returns and Allowances 🔒
🟡 Modified Other Tax Matters 🔒
🟡 Modified Definition and Limitations of Internal Control Over Financial Reporting 🔒
🟡 Modified Revenue Recognition 🔒
174 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get full access — from $29/month Already a Pro subscriber? View full diff →